Genetic interaction in the susceptibility of rheumatoid arthritis. (22nd February 2011)

• Record Type: Journal Article
• Authors: Daha, Nina A; Willemze, Annemiek; Robinson, David B; Oen, Kiem G; Smolik, Irene; Hart, Donna; Ghidey, Wendimagegn; Houwing-Duistermaat, Jeanine J; Siminovitch, KA; Huizinga, Tom WJ; El-Gabalawy, Hani S; Toes, René EM
• Is Part Of: Annals of the rheumatic diseases. Volume 70(2011)Supplement 2
• Page Start: A84
• Page End: A84
• Publication Date: 2011-02-22
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/ard.2010.149021.5
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Introduction: Recent advances have revolutionised the identification of genes underlying common diseases. For rheumatoid arthritis (RA), over 20 genes have been identified to associate to disease susceptibility. The strongest of these genetic associations is with particular genes within the human leucocyte antigen (HLA) region. To date, however, little is known about underlying relations between genes on a genetic level, which provides more insight into biological pathways involved. In the current study the authors investigated this for the strongly associated HLA region in a North American Native population. This population has a high RA prevalence rate with multicase families and, most importantly, a high prevalence of shared epitope alleles in the background population. Methods: RA gene polymorphisms, identified previously, 1 were genotyped in 333 North American Native RA patients, 295 first degree relatives and 490 unrelated controls. HLA-DRB1 alleles were tested by sequencing. Allele distribution was analysed using a χ 2 test with one degree of freedom and as interaction criteria departure from multiplicative effects was used. Significant associations were tested for replication in a Dutch RA population (n=918) and controls (n=1309). Results: A significant association was detected for MMEL1-TNFRSF14 in the Native American population (OR 1.45, 95% CI 1.09 to 1.94, p=0.009), with a significant association in the shared epitope positive group and not in the shared epitope negative group (OR 1.66, 95% CI 1.20 to 2.30, p=0.002 and OR 0.85, 95% CI 0.47 to 1.55, p=0.60, respectively). Analysis in the Dutch population demonstrated a similar trend in RA association (shared epitope positive group: OR1.31, 95% CI 1.0 to 1.70, p=0.04; shared epitope negative group: OR 1.11, 95% CI 0.81 to 1.53, p=0.51), but significant statistical evidence for interaction could not be established. Conclusion: In the current study the authors demonstrate a novel interaction between the HLA region and MMEL1-TNFRSF14 in a Native American population, with a similar trend in a Dutch population of RA patients. This interaction is particularly important since shared epitope alleles are highly present in the Native American population, yet most individuals stay disease free. This finding might give more insight into biological pathways involved in disease and therefore give rise to future therapeutic targets.